Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03874169 · ClinicalTrials.gov registry record
Detection of Gastrointestinal Bleeding in Intensive Care Patients Via Biosensor Watch
A clinical trial, sponsored by Columbia University.
- Terminated
- Registry status
- 20
- Enrollment target
NCT03874169: Clinical Trial study, sponsored by Columbia University.
NCT03874169 is a clinical trial that was terminated before completion, run by Columbia University. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03874169 was terminated before completion, sponsored by Columbia University.
- TERMINATED
- Registry status
- 20 participants
- Enrollment target
Study Summary
The purpose of this study to improve methods of monitoring and diagnosing gastrointestinal bleeding via the E4 wristband, a biosensor watch.
Primary Outcome
Using the wristband, heart rate will be collected at a frequency of 64 Hz.
Interventions
- DEVICE E4 wristband
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2019-03-29 |
| Est. Completion | 2021-07-20 |
Why NCT03874169 stopped before completion
NCT03874169 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which E4 wristband is the first listed.
NCT03874169 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03874169 about?
NCT03874169 is a clinical study titled "Detection of Gastrointestinal Bleeding in Intensive Care Patients Via Biosensor Watch". The purpose of this study to improve methods of monitoring and diagnosing gastrointestinal bleeding via the E4 wristband, a biosensor watch.
What is the current status of trial NCT03874169?
This trial is currently terminated. The enrollment target is 20 participants. The study started on 2019-03-29. Estimated completion is 2021-07-20.
What interventions are being tested in trial NCT03874169?
The interventions under investigation include: E4 wristband (DEVICE).
Who is sponsoring clinical trial NCT03874169?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI